Quince Therapeutics, Inc. (QNCX)

CIK 1662774 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Quince Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 4, 20268-K0001193125-26-382838
Aug 27, 20268-K0001193125-26-371389
Aug 25, 2026DEF 14A0001193125-26-364220
Aug 24, 2026EFFECT9999999995-26-002741
Aug 17, 20268-K0001193125-26-353141
Aug 14, 20268-K0001193125-26-350568
Aug 14, 2026SCHEDULE 13G0001172661-26-003692
Aug 14, 202610-Q0001193125-26-352201
Aug 14, 2026SCHEDULE 13G0001172661-26-003433
Aug 14, 2026SCHEDULE 13G0001193125-26-352966
Aug 14, 2026SCHEDULE 13G/A0001104659-26-097291
Aug 5, 2026S-3/A0001193125-26-333764
Aug 4, 2026SCHEDULE 13G0002050709-26-000021
Jul 31, 20268-K0001193125-26-328784
Jul 31, 2026PRE 14A0001193125-26-328777
Jul 31, 2026S-30001193125-26-328769
Jul 30, 20268-K/A0001193125-26-324786
Jun 26, 20268-K0001193125-26-284089
Jun 26, 20268-K/A0001193125-26-285572
Jun 15, 202640000912282-26-000832
Jun 15, 202640000912282-26-000830
Jun 11, 20268-K0001193125-26-267862
Jun 11, 2026D0000912282-26-000809
Jun 11, 202640001346566-26-000004
Jun 11, 2026D0000912282-26-000811